Jeffrey Blizard's most recent trade in Sanuwave Health Inc was a trade of 1,761 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 3, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Sanuwave Health Inc | Jeffrey Blizard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2025 | 1,761 | 1,761 | - | - | Stock Option (right to buy) | |
TELA Bio Inc | Jeffrey Blizard | Director | 04 Jun 2024 | 9,300 | 9,300 | - | - | Stock Option (Right to Buy) | ||
TELA Bio Inc | Jeffrey Blizard | Director | 04 Jun 2024 | 6,375 | 6,375 (0%) | 0% | 0 | Common Stock |